Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Status:
RECRUITING

Trial end date:
2028-02-28

Target enrollment:

Participant gender:

Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.

PHASE3

Incyte Corporation